IMM Report Number 34

In conjunction with Foresight Update 50

Recent Progress: Steps Toward Nanotechnology

By Jim Lewis


[Editor’s note: Because of the effort required to cover the 10th Foresight Conference on Molecular Nanotechnology for this issue of Update, this Recent Progress column will depart from its usual format and summarize one important overview article. The usual practice of reporting several recent research papers will return next issue.]

Jim Lewis

The theme of the following paper is the utilization of biological structure to organize non-biological materials, introducing molecular recognition and complexity of structural organization not otherwise available. The paper is not a primary research publication, but actually an invited contribution from the Recipient of the American Chemical Society Award in Pure Chemistry, given to Chad A. Mirkin of Northwestern University in 1999. Note that Chad Mirkin is also the winner of the 2002 Foresight Institute Feynman Prize (in the Experimental work category, see previous story). The paper below is noteworthy not as a report of a new advance, but as a review of a method that appears very promising.

“Programming the Assembly of Two- and Three-Dimensional Architectures with DNA and Nanoscale Inorganic Building Blocks” Chad A. Mirkin. Inorg. Chem. 2000, 39, 2258-2272.

“The use of biochemical molecular recognition principles for the assembly of nanoscale inorganic building blocks into macroscopic functional materials constitutes a new frontier in science. This article details efforts pertaining to the use of sequence-specific DNA hybridization events and novel inorganic surface coordination chemistry to control the formation of both two- and three-dimensional functional architectures.”

The projects Mirkin describes are clearly purposed as a “general methodology for preparing nanostructured materials with predefined, synthetically programmable properties from common inorganic building blocks and readily available DNA interconnect molecules.” Mirkin’s goals in pursuing these projects are both pure science and near-term to mid-term technological applications. He wants to understand how DNA molecules can interact to organize nanoscale building blocks into organized materials, and he wants to determine “the physical and chemical consequences of miniaturization.”

In terms of technological applications, the most direct application would be to use the ability of the correct DNA sequence to organize some nanostructure so as to change some optical or other physical property, thus generating a very sensitive signal that a specific DNA sequence had been detected. Very sensitive, rapid, and convenient assays for specific DNA sequences mean, for example, very sensitive, rapid, and convenient assays for biowarfare agents and other pathogens. Looking somewhat further ahead, Mirkin anticipates using DNA-guided building blocks to assemble high performance catalysts and to link electronic devices together into nanometer-scale electronic circuits.

The first challenge Mirkin addresses is to prepare biomolecular building blocks) by “developing methods for functionalizing small inorganic building blocks with DNA and then using the molecular recognition properties associated with DNA to guide the assembly of those particles or building blocks into extended structures. Our aim is to be able to control the particle chemical composition, the particle size, the distance between the particles, and the strength of the interactions between the particles in the resulting nanostructured materials.” The general significance of such capabilities is apparent. “Why? If we can do this, we can, in principle, control all the important properties of the resulting structures.”

As possible nanoparticles to link together with DNA, Mirkin lists a variety of metals, semiconductors, magnetic oxides, and polymers, ranging from one nm to one micrometer in diameter. Each type of particle presents a different challenge in terms of the chemistry to be used to functionalize the surface so that DNA molecules can be attached to the surface. Finding a suitable chemistry to attach DNA to a specific nanoparticle surface can be a non-trivial problem. For example, significant non-specific interactions among particles can overshadow any specific interactions among the DNA stands attached to the particles.

Another factor to consider is how easy it is to make nanoparticle that are of proper and more or less uniform size. Gold nanoparticles were chosen for the first experiments because they are convenient to prepare as 13-nm particles. These nanoparticles have the further advantage of being very intensely colored. In addition, because the particles carry a net positive electical charge, the average distance between particles will decrease if salt is added because the ions from the salt partially screen the positive charges on the particles from each other. This change in separation distance causes the color to turn from red to blue.

The big step was to see whether DNA molecules could link such nanoparticles together into a network pre-determined by the base-pairing specificities of the DNA moleulces used. The functionalization chemistry used permitted loading about 220 short single-strand DNA molecules (called oligonucleotides) per 13-nm gold particle, although because of steric constraints (crowding) only about 15% of these would be available to bind to the appropriate partner strand. If two batches of DNA-loaded nanoparticles bearing non-complementing DNA sequences are mixed together, nothing happens because the non-complementing DNA oligonucleotides do not bind to each other. However, if a third, free DNA strand is added that has portions complementary to each of the first two oligonucleotides, then the added third strand forms double-strand DNA with each of the the first two, and the particles are linked together by the bridging DNA molecules into a network, causing the color of the solution to change from red to blue. This change can be reversed by heating, which “melts” the DNA pairing, allowing the particles to separate, turning the solution red again. Cooling causes the duplex DNA to reform, turning it blue. The system can be repeatedly cycled between room temperature and 80 °C.

Mirkin and his collaborators demonstrated by this simple and elegant experiment that DNA can be use to assemble nanoparticles into an aggregate in a way that depended on the sequence of the DNA. Others, most notably Ned Seeman and his group, have used DNA by itself to build complex nanostructures and even nanomechanical devices. The advantage Mirkin claims for the hybrid DNA/nanoparticle approach over using DNA alone is that the nanoparticles provide a variety of ways to follow the assemly process and characterize the products.

“I have always said and still maintain today that DNA is the quintessential building block for materials synthesis. The advantage of using DNA as a materials synthon rather than a conventional organic interlink molecule is that it is synthetically programmable and very predictable from a reactivity standpoint. With DNA, most of the structures that we write on the black board can be prepared in the laboratory, provided that we understand the simple basepairing interactions of DNA. The beauty of working with hybrid inorganic/DNA structures is that we have an enormous characterization- capability advantage over those who work with materials made solely of DNA.”

The reversible nature of the DNA-guided aggregation testifies to the fact that the DNA not only guides the assembly of the nanoparticles, but protects them from fusing once assembled, even when the aggregate reaches macroscopic size. Although such aggregates might appear to casual observation to be merely “blobs,” they are in fact macroscopic structures with nanometer-scale order.

How complicated a structure is it possible to build using such methods? Certainly different types of particles can be linked together. Mirkin mixes a large excess of 8-nm particles with 31-nm particles, and shows images of “satellite structures” of a 31-nm particle circled by 8-nm ones.

Mirkin’s immediate interest is in adapting this technology to detecting trace amounts of DNA, as in biowarfare agent detection. The system has major advantages for this purpose— for one thing a 13-nm nanoparticle has a molar extinction coefficient a thousand-fold greater than the best organic dyes. There are also features of the DNA-nanoparticle network that Mirkin cleverly exploits that make diagnostic applications of this technology inherently more selective than competing technologies.

However, from a molecular manufacturing standpoint, the really interesting questions are the ones that are not addressed here. How complex a structure can be assembled using DNA base-pairing to guide the assembly? How many components? How precisely can the components be oriented with respect to each other in space? With the work of Seeman and his colleagues building nanostructures from DNA alone, initial results were that DNA base-pairing conferred the proper topological connected-ness to the desired structures, but the junctions formed were too loose to enforce real shapes until a second generation type of junction was designed with greater angular rigidity (see Update 35). Can one do as well or better with the hybrid DNA/nanoparticle approach described here?

The remainder of the article covers another of Mirkin’s areas of research, a type of lithography capable of drawing molecule-based patterns with sub-100-nm resolution that he and his colleagues have termed dip-pen-nanolithography. Dip-pen-nanolithography (DPN) uses the tip of an AFM to write lines one molecule thick and 30 – 70 nm wide, quickly and conveniently under ambient conditions. When writing on a single-crystal gold surface, even finer resolution can be obtained — 15 nm dots spaced 5 nm apart. Unlike the usual situation with scanning probe microscopes, it is possible in the case of DPN to easily locate a previously written nanostructure. This ease of alignment allows complex nanostructures to be written using several different molecules as ink. Thus DPN looks very promising for molecule-based electronics. It can “generate very sophisticated architectures and interface them with macroscopically addressable, microscopic circuitry.” Perhaps even more exciting is the demonstration that DPN can draw 30-nm-wide lines of DNA chemisorbed on a gold surface. In theory, each line could be drawn with a different DNA sequence. Combined with the DNA-functionalized building blocks described above, DPN opens the way to programming nanoparticle-based architectures.

Taking Mirkin’s work together with the work of Seeman and others, one wonders whether DNA can do for nanotechnology what it did for biology?

IMM would appreciate learning your thoughts on the above article.

IMM Report Number 37

In conjunction with Foresight Update 51

Recent Progress: Steps Toward Nanotechnology

By Jim Lewis



Jim Lewis

Learning to control nature’s molecular machinery

“Control of a biomolecular motorpowered nanodevice with an engineered chemical switch,” by H Liu, JJ Schmidt, GD Bachand, SS Rizk, LL Looger, HW Hellinga, and CD Montemagno, of UCLA, Sandia National Laboratories, and Duke Uniersity. Nature Materials 1: 173-177 (Nov. 2002)

Reporting continuing progress in the efforts of Carlo Montemagno and his collaborators to harness a biochemical rotary motor in a hybrid biological-inorganic nano-engineered system (see Update 44), this paper presents “… the rational design, construction and analysis of a mutant F1-ATPase motor containing a metal-binding site that functions as a zinc-dependent, reversible on/off switch. Repeated cycles of zinc addition and removal by chelation result in inhibition and restoration, respectively, of both ATP hydrolysis and motor rotation of the mutant, but not of the wild-type F1 fragment. These results demonstrate the ability to engineer chemical regulation into a biomolecular motor and represent a critical step towards controlling integrated nanomechanical devices at the single-molecule level.”

Armed with an atomically detailed picture of the structure and function of the ATP-driven molecular motor and computational tools that reliably design de novo metal-binding centers in proteins of known structure, the researchers set about designing a site that would reversibly bind zinc ions. Binding the zinc causes a change in the structure of protein subunits that prevents those subunits from interacting in the way that is necessary to split the ATP molecule to provide energy for rotation. Thus binding zinc could be used to control the activity of the enzyme. To make the change reversible, the zinc can be removed by chelation with a molecule like 1,10 phenanthroline, which will sequester zinc, but would not bind magnesium ions, which are essential for the enzyme to function.

The mutant enzyme had the same ability to split ATP as did the original (or “wild-type”) enzyme when tested in the absence of zinc ions, but 60% less activity when zinc was added. To look directly at the rotation of individual motor molecules, the protein motor molecules were tethered to microspheres bound to a glass coverslip, and the ability of the motor to rotate a fluorescently labeled actin filament (a long protein molecule) measured by fluorescence microscopy. The mechanical properties of the mutant motor proteins were the same as of the wild-type motor proteins in the absence of zinc; i.e., actin rotors of the same length rotated at the same rate. Introducing zinc caused 100% of the mutant protein motors, but none of the wild-type protein motors, to stop rotating. The authors attribute the different between shutting off 100% of the rotation, but only 60% of the ATP hydrolysis, to the possibility that some ATP hydrolysis can occur without producing mechanical rotation. Calculations estimate an average value for the torque of 34 pN nm for both mutant and wild-type proteins. The authors note:

“Our method maintains the presence of fuel (ATP), does not affect the mechanical properties of the motors and does not affect the activity of other ATP-dependent enzymes. These experiments represent critical steps in the realization of logical and useful biomolecular motor-powered structures. The technology may be extended through engineering of secondary binding sites to other pre-selected ligands. Aside from use as a mechanical actuator, the introduction of a secondary mechanism to control motor functionality also may allow sensing and feedback control of the motor and associated devices.”

Naturally occurring diamondoid building blocks

Several years ago Ralph Merkle considered the use of diamond-like hydrocarbon molecules as possible building blocks for developing molecular manufacturing methods (see “Molecular building blocks and development strategies for molecular nanotechnology”, available in draft form at http://www.zyvex.com/nanotech/mbb/mbb.html). The size and complexity of building blocks of this type actually available in the laboratory was substantially increased with the publication of: “Isolation and Structure of Higher Diamondoids, Nanometer-Sized Diamond Molecules,” by JE Dahl, SG Liu, and RMK Carlson of ChevronTexaco, Science 299: 96-99 (3 January 2003). The discovery in petroleum of “higher diamondoids,” clusters of 4 to 11 diamond-crystal cages fused together to give molecules of ~1 to 2 nm in size, received extensive press coverage from the standpoint that these molecules could be very useful as building blocks for nanotechnology (see Nanodot story http://nanodot.org/articles/03/02/21/0917256.shtml).

Diamondoids are hydrocarbons in which all of the carbon atoms are arranged in space in a tetrahedral framework (sp3 electron configuration) just as they are inside a diamond lattice, and with the dangling bonds terminated with hydrogen atoms, as are the surface carbon atoms in diamond. The smallest diamondoid is adamantane (C10H16), in which 10 C atoms are fused into three rigid, overlapping 6-member rings so that they maintain the same tetrahedral spatial relationships to each other that they have in a diamond crystal, with the 16 dangling bonds terminated with H atoms. The next member in the series is diamantane (C14H20), in which two adamantane diamond-crystal cages are fused along a common face to give five overlapping 6-member rings. Adding a third diamond-crystal cage gives triamantane (C18H24). With the next addition, tetramantane (C22H28), the diamond-crystal cages can have different arrangements in space, resulting in isomers of different shape and, in some cases, different chirality (mirror image forms). Beyond tetramantane there are not only isomers in which the atoms are arranged in different shapes, but the number of atoms can vary a bit depending on just how the additional diamond-crystal cages are fused together. With five diamond-crystal cages, there are nine isomers with the formula C26H32, and one isomer with the formula C25H30.

The lower diamondoids, with 1, 2, and 3 adamantane cages were previously found in petroleum and have been chemically synthesized, but the attempts to synthesize the higher diamondoids were unsuccessful. The authors isolated higher diamondoids from petroleum, heating as high as 450°C to remove non-diamondoids. After various purification by chromatography, the authors crystallized all four tetramantanes, nine pentamantanes, one hexamantane, two heptamantanes, two octamantanes, one nonamantane, one decamantane, and one undecamantane. They determined single-crystal x-ray structures for representatives from three families.

The authors found a great variety of three-dimensional molecular shapes, including rods, disks, and helices. “A series of rod-shaped higher diamondoids have long axes perpendicular to their diamond (110) lattice planes, the shortest being [121] tetramantane at a length of 1.0 nm… Another of the hexamantanes, [12312] hexamantane or cyclohexamantane, is a disc-shaped molecule. Additionally, two series of screw-shaped higher diamondoids have different helical pitches and diameters and helical axes that are parallel to different diamond crystal planes … Molecules of both series are rare primary helical structures, where the helicity is inherent in the backbone of the molecule (rather than arising from steric effects, such as in the helicenes).”

The authors report preparing a number of chemically functionalized derivatives, and note “Predictable and diverse derivatizable geometries are important features for molecular self-assembly…” The authors cite advantages of these molecules for drug design and electronic properties, but they do also reference Drexler’s Nanosystems in terms of “suggesting possible applications in nanotechnology”. The wide variety of rigid, diverse shapes that can be chemically functionalized substantially expands what was available in the laboratory three years ago when Merkle first published the possible use of adamantanes as molecular building blocks.

Building metallic circuits with DNA

With much progress in the development of molecular electronic devices, at least three research groups have turned to the unique molecular recognition advantages of DNA to approach the challenge of assembling such devices into functional circuits. The three papers considered below use DNA to arrange metal ions, although to very different precision and scale.

“Sequence-Specific Molecular Lithography on Single DNA Molecules” by K Keren, M Krueger, R Gilad, G Ben-Yoseph, U Sivan, and E Braun of Technion-Israel Institute of Technology, Science 297: 72-75 (5 July 2002). In a process they call molecular lithography, an Israeli group uses complexes of DNA and a protein called “RecA”, which facilitates three-way junctions with different DNA strands, as template and “resist” to build and connect metallic wires onto semiconducting surfaces. The authors had previously shown (see Update 33) that DNA molecules could be uniformly coated with metal to form thin metallic wires that could be attached to macroscopic electrodes by base-pairing between complementary DNA sequences.

RecA is the major protein that mediates the process of homologous recombination in the laboratory bacterium E. coli. In this process, many molecules of the RecA protein bind to a single strand of DNA (ssDNA). The DNA-protein complex can then bind to a dsDNA (double-helical DNA) if there is substantial homology between the ssDNA and dsDNA, such as a section of at least 30-50 bases where the ssDNA and dsDNA molecules have identical or nearly identical sequences. The ssDNA-protein complex can then bind at that region of homology, displacing one strand of the dsDNA and taking its place in the double helix. These properties of the RecA and DNA complex can thus be exploited to (1) facilitate binding of a ssDNA probe to a specific section of a long DNA molecule, (2) form a three-way junction between a ssDNA and a dsDNA molecule, and (3) protect a specific section of DNA from chemical derivatization by virtue of bound molecules of RecA protein (i.e., function as a resist). Thus RecA can be exploited to produce a network of DNA molecules that are coated with metal in some specific places.

In one experiment, the authors used RecA to place a 2027-base ssDNA on the homologous section of a 48,502-base pair dsDNA molecule (a bacterial virus) that had first been treated with aldehyde to render it susceptible to treatment with silver ions. Silver aggregates form where the DNA is unprotected by RecA, and the silver-dotted section then becomes a target for gold deposition, converting the DNA regions unprotected by RecA into a conductive gold nanowire. The DNA molecules were stretched out on chemically treated silicon wafers and imaged by AFM. The gold coated DNA molecules are 50-100 nm wide (compared to a little more than 2 nm for uncoated dsDNA) and up to a dozen microns in length. Other experiments indicate the formation of a three-way junction to build a Y-shape complex from two dsDNA molecules, and in still other experiments, the ability to attach other types of nanoparticles along a gold-DNA nanowire to nm precision. Although this method allows nm-precision in placing elements along a nanowire, and in where two nanowires connect, the wires are relatively thick (50-100 nm), microns in length, and are connected topologically, but not constrained as to their exact positions on a two dimensional surface so that the nanometer-precision only extends along the wire, not in two dimensions.

“Selfassembly of metallic nanoparticle arrays by DNA scaffolding” by S Xiao, F Liu, AE Rosen, JF Hainfeld, NC Seeman, K Musier-Forsyth, and Richard A. Kiehl of the University of Minnesota, New York University, and Brookhaven National Laboratory, Journal of Nanoparticle Research 4: 313-317, 2002.

These authors exploit the earlier work of Seeman and his colleagues (Update 35) that used rigid double-crossover DNA molecules to construct crystals capable of tiling a surface. With such programmable molecular scaffolding, they were able to assemble arrays of 1.4-nm diameter (55 Au atoms) gold nanoparticles with interparticle spacings of 4 nm and 64 nm. On the other hand, the unusual DNA molecules used for these two dimensional crystals require “aqueous environments containing significant concentrations of multivalent cations”, substantially different from the usual conditions in nanoelectronic applications. The 2-D DNA crystals assembled in solution (via base-pairing of complementary sequences on different molecules) from 22 specifically designed synthetic oligonucleotides (each a few dozen nucleotides in length), some of which were designed to have structural features protruding from the plane. The gold nanoparticles were designed to attach to those protruding structures via a 6-carbon atom linker.

The 2D DNA crystals were examined by atomic force microscopy (AFM), transmission electron microscopy (TEM), and scanning transmission electron microscopy (STEM). Gold nanoparticles were seen in arrays with the spacing expected from the crystal design —4 nm between particles in lines 64 nm apart. Gold nanoparticles were attached to the crystal array at about 70% of the 4 nm by 64 nm lattice points, indicating incomplete attachment. Thus this technology gives programmable 2-D arrays with one-base pair precision (0.34 nm) in both dimensions, although the chemistry has not been optimized and the aqueous environment might be problematic for some applications.

“A Discrete Self-Assembled Metal Array in Artificial DNA” by K Tanaka, A Tengeiji, T Kato, N Toyama, and M Shionoya of the University of Tokyo and the Institute for Molecular Science, Science 299: 1212-1213 (21 Feb. 2003).

In this case, metal ions are introduced directly into the helical duplex of a DNA-like structure. The authors had previously showed they could replace the hydrogen-bonded base pairing present in natural DNA by metal-mediated base pairing of artificial bases, leading to “metallo-DNA,” in which metal ions were lined up along the helix axis. An advantage of this approach is that they are able to use conventional DNA solid state synthesis chemistry to incorporate such metal-containing artificial DNA at any position in a conventional DNA molecule.

In these experiments, they use a hydroxypyridone nucleobase (H) that forms, with concomitant deprotonation, a stable, neutral complex with a divalent Cu2+ ion (H– Cu2+H). They synthesized 3- to 7-nucleotide self-complementary DNA molecules of the type 5′-G HnC-3′, where n=1-5. These molecules do not form duplex structures in the absence of Cu2+ because two G-C pairs would not provide enough conventional base-pairing to form a duplex. UV-absorption changes of these molecules in solution showed that upon adding Cu2+, the molecules did form duplex structures. Circular dichroism (CD) spectra of the duplexes were consistent with the formation of right-handed, double-stranded DNA. Continuous-wave electron paramagnetic resonance (CW-EPR) spectra of the duplexes indicated the formation of magnetic chain by stacking of the Cu2+ within the DNA helix. The distance between the Cu2+ ions (0.37 nm) is similar to the distance between bases pairs in conventional DNA (0.33 to 0.34 nm).

The authors conclude “This strategy represents a method for arranging metal ions in solution in a discrete and predictable manner and contrasts with the non-biological approach of other methods, leading to the possibility of metal-based molecular devices such as molecular magnets and wires.”

IMM would appreciate learning your thoughts on the above article.

IMM Reports

Topics in Molecular Manufacturing

No. 55. Comprehensive Nanorobotic Cure for Male Erectile Dysfunction
by Robert A. Freitas Jr. Published November 2024.
No. 54. How Much Nanomachinery Can We Have on Earth?
by Robert A. Freitas Jr. Published July 2024.
No. 53. Cell Mills: Nanofactory Manufacture of Biological Components
by Robert A. Freitas Jr. Published June 2024.
No. 52. Hairbots: The Future of Nanorobotic Coiffure
by Robert A. Freitas Jr. Published April 2024.
No. 51. Nanofactory-Based Environmental Remediation: Cleanup of Polluted Oil Sands Tailings Pond Water in Alberta, Canada
by Robert A. Freitas Jr. Published April 2023.
No. 50. Energy Density
by Robert A. Freitas Jr. Published June 2019.
No. 49. New Technologies and Climate Change
by Ralph C. Merkle Published June 2017.
No. 48. The Alzheimer Protocols: A Nanorobotic Cure for Alzheimer’s Disease and Related Neurodegenerative Conditions
by Robert A. Freitas Jr. Published June 2016.
No. 47. The Whiskey Machine: Nanofactory-Based Replication of Fine Spirits and Other Alcohol-Based Beverages
by Robert A. Freitas Jr. Published May 2016.
No. 46. Molecular Mechanical Computing Systems
by Ralph C. Merkle, Robert A. Freitas Jr., Tad Hogg, Thomas E. Moore, Matthew S. Moses, James Ryley Published March 2016.
No. 45. The Nanofactory Solution to Global Climate Change: Atmospheric Carbon Capture
by Robert A. Freitas Jr. Published December 2015.
No. 44. Molecular Space Frames: An Atomically Precise Aerogel
by Ralph C. Merkle Published January 22, 2014.
No. 43. Diamond Trees (Tropostats): A Molecular Manufacturing Based System
for Compositional Atmospheric Homeostasis

by Robert A. Freitas Jr. Published February 10, 2010.
No. 42. Nanomedicine: Will Intracellular Medical Nanorobots Disrupt the Cytoskeleton (Part II)?
by Robert A. Freitas Jr. Published January 15, 2004.
No. 41. Recent results in SRMS
by J. Storrs Hall. Published January 15, 2004.
No. 40. Steps Toward Nanotechnology
by Jim Lewis. Published August 31, 2003.
No. 39. Progress in Thinking Machines
by J. Storrs Hall. Published August 31, 2003.
No. 38. Nanomedicine: Will Intracellular Medical Nanorobots Disrupt the Cytoskeleton (Part I)?
by Robert A. Freitas Jr. Published April 15, 2003.
No. 37. Steps Toward Nanotechnology
by Jim Lewis. Published April 15, 2003.
No. 36. Disasters
by J. Storrs Hall. Published April 15, 2003.
No. 35. Nanomedicine: Is Sapphire Biocompatible With Living Cells?
by Robert A. Freitas Jr. Published November 30, 2002.
No. 34. Steps Toward Nanotechnology
by Jim Lewis. Published November 30, 2002.
No. 33. Nanomedicine: Could Medical Nanorobots Be Carcinogenic?
by Robert A. Freitas Jr. Published August, 2002.
No. 32. Steps Toward Nanotechnology
by Jim Lewis. Published August, 2002.
No. 31. Nanomedicine: The Vasculoid Personal Appliance
by Robert A. Freitas Jr. Published March 31, 2002.
No. 30. Steps Toward Nanotechnology
by Jim Lewis. Published March 31, 2002.
No. 29. Nanomedicine: Volumetric Cellular Intrusiveness of Medical Nanorobots
by Robert A. Freitas Jr. Published December 31, 2001.
No. 28. Nanomedicine: How Nanorobots Can Avoid Phagocytosis by White Cells, Part II
by Robert A. Freitas Jr. Published September 30, 2001.
No. 27. Nanomedicine: How Nanorobots Can Avoid Phagocytosis by White Cells, Part I
by Robert A. Freitas Jr. Published June 30, 2001.
No. 26. Steps Toward Nanotechnology
by Jeffrey Soreff. Published June 30, 2001.
No. 25. Nanomedicine: Microbivores, Artificial Mechanical Phagocytes
by Robert A. Freitas Jr. Published April 1, 2001.
No. 24. Steps Toward Nanotechnology
by Jeffrey Soreff. Published April 1, 2001.
No. 23. Highlights from the Eighth Foresight Conference On Nanotechnology
by Jeffrey Soreff. Published December 30, 2000.
No. 22. Nanomedicine: Nanopyrexia
by Robert A. Freitas Jr. Published December 30, 2000.
No. 21. Self-Replication and Pathways to Molecular Nanotechnology
by J. Storrs Hall. Published December 30, 2000.
No. 20. Nanomedicine: Will Serum Proteins Stick to Nanorobot Surfaces?
by Robert A. Freitas Jr. Published September 30, 2000.
No. 19. Steps Toward Nanotechnology
by Jeffrey Soreff. Published September 30, 2000.
No. 18. Nanomedicine: Clottocytes, Artificial Mechanical Platelets
by Robert A. Freitas Jr. Published June 30, 2000.
No. 17. Steps Toward Nanotechnology
by Jeffrey Soreff. Published June 30, 2000.
No. 16. Diamond in the Sky
by J. Storrs Hall. Published March 31, 2000.
No. 15. Announcing the Opening of the Nanomedicine Art Gallery
by Robert A. Freitas Jr. Published March 31, 2000.
No. 14. Steps Toward Nanotechnology
by Jeffrey Soreff. Published March 31, 2000.
No. 13. Steps Toward Nanotechnology
by Jeffrey Soreff. Published December 30, 1999.
No. 12. Nanomedicine: Is Diamond Biocompatible With Living Cells?
by Robert A. Freitas Jr. Published December 30, 1999.
No. 11. Steps Toward Nanotechnology
by Jeffrey Soreff. Published September 30, 1999.
No. 10. Steps Toward Nanotechnology
by Jeffrey Soreff. Published July 30, 1999.
No. 9. Steps Toward Nanotechnology
by Jeffrey Soreff. Published March 30, 1999.
No. 8. Building Molecular Machine Systems [a preprint]
by K. Eric Drexler. Published January 13, 1999.
No. 7. Reflexive Capabilities
by J. Storrs Hall. Published January 11, 1999.
No. 6. Steps Toward Nanotechnology
by Jeffrey Soreff. Published December 14, 1998.
No. 5. IMM Update: Current Status and Future Directions
by Neil Jacobstein. Published October 21, 1998.
No. 4. Molecular Manufacturing and the Private Aircar
by J. Storrs Hall. Published October 21, 1998.
No. 3. Steps Toward Nanotechnology
by Jeffrey Soreff. Published August 13, 1998.
No. 2. Recent Progress: Steps Toward Nanotechnology
by Jeffrey Soreff. Published July 17, 1998.
No. 1. NIST Holds Microsystems/Nanosystems Meeting
by J. Storrs Hall. Published January 29, 1998.